Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,324 | 19,189 | 22,523 | 17,303 | 19,094 |
| TOTAL | $17,110 | $21,078 | $24,028 | $19,000 | $21,035 |
| Non-Current Assets | |||||
| PPE Net | 17 | 20 | 22 | 25 | 47 |
| Intangibles | 1,867 | 1,867 | 1,867 | 1,867 | 1,867 |
| Other Non-Current Assets | 934 | 0 | 0 | 0 | 70 |
| TOTAL | $2,818 | $1,887 | $1,889 | $1,892 | $1,984 |
| Total Assets | $19,928 | $22,965 | $25,917 | $20,892 | $23,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 751 | 706 | 449 | 418 | 189 |
| Accrued Expenses | 852 | 746 | 1,170 | 1,022 | 2,117 |
| TOTAL | $1,603 | $1,452 | $1,619 | $1,440 | $2,306 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 94 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $94 |
| Total Liabilities | $1,603 | $1,452 | $1,619 | $1,440 | $2,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 524 | 524 | 523 | 523 | 394 |
| Common Shares | 9 | 9 | 9 | 7 | 7 |
| Retained earnings | -36,997 | -33,501 | -30,312 | -27,506 | -25,396 |
| TOTAL | $18,325 | $21,513 | $24,298 | $19,452 | $20,619 |
| Total Liabilities And Equity | $19,928 | $22,965 | $25,917 | $20,892 | $23,019 |